Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ronald D. Fitzmartin"'
Autor:
Tammy Jackson, Frank Pétavy, Barbara Jauregui, Jose Galvez, Lynn D. Hudson, Denise Warzel, Rebecca Daniels Kush, Eileen A. Navarro, Ronald D. Fitzmartin, Lauren B. Becnel, Alexander Sherman, F. L. Zhou, Nicole Harmon, Maura A. Kush
Publikováno v:
Journal of biomedical informatics. 107
The value of robust and responsible data sharing in clinical research and healthcare is recognized by patients, patient advocacy groups, researchers, journal editors, and the healthcare industry globally. Privacy and security concerns acknowledged, t
Autor:
Ronald D. Fitzmartin, Kim Nitahara
Publikováno v:
Drug Information Journal. 35:671-679
Over the past decade, internal and external pressures on the biopharmaceutical industry have posed the challenge of decreasing the time and cost associated with product development, in particular, the clinical trials process. While cost and time must
Autor:
Ronald D. Fitzmartin
Publikováno v:
Drug Information Journal. 32:745-756
The international drug development environment is characterized by tremendous pressure to reduce health care costs, increasing government regulations, longer product development time, and shorter marketing exclusivity. Throughout the 1980s and 1990s
Autor:
Ronald D. Fitzmartin, Robert F. Reder, Paul Goldenheim, David P. Benziger, Robert F. Kaiko, Brian E. Burke
Publikováno v:
Clinical Pharmacology & Therapeutics. 59:52-61
Plasma concentrations of oxycodone, oxymorphone, and noroxycodone were determined after administration of 20 mg oral controlled-release oxycodone tablets to four subject groups: young (aged 21 to 45 years) men, elderly (aged 65 to 79 years) men, youn
Autor:
James Komorowski, Jeanette Mitchell, Tom P Barden, Robert F. Kaiko, Paul Goldenheim, Gail B Cissell, Saul S Bloomfield, Ronald D. Fitzmartin, R. Grandy
Publikováno v:
Clinical Pharmacology and Therapeutics. 53:469-478
MS Contin tablets and Oramorph SR tablets are two forms of oral controlled-release morphine sulfate available for the alleviation of pain. Our objective was to compare their analgesic effects in a relative potency assay. In this study, 151 patients u
Autor:
Ronald D. Fitzmartin
Publikováno v:
Drug Information Journal. 35:639-641
Autor:
Abraham Sunshine, Robert F. Reder, Ronald D. Fitzmartin, Paul Goldenheim, Juana Rivera, Robert F. Kaiko, Ariel Colon, Nancy Z. Olson
Publikováno v:
Journal of clinical pharmacology. 36(7)
The efficacy and safety of graded doses (10, 20, and 30 mg) of controlled-release (CR) oxycodone was compared with that of immediate-release (IR) oxycodone (15 mg), immediate-release oxycodone 10 mg in combination with acetaminophen 650 mg (APAP), an
Autor:
Robert F. Reder, Jahanara B. Miotto, Ronald D. Fitzmartin, David P. Benziger, Robert F. Kaiko, Mark Chasin
Publikováno v:
Journal of pharmaceutical sciences. 85(4)
The effects of a high-fat meal on the bioavailability of oxycodone hydrochloride, administered as a recently developed 40 mg controlled-release (CR) tablet or a 20 mg immediate-release (IR) solution, were evaluated in a randomized crossover study in
Autor:
Ronald D. Fitzmartin
Publikováno v:
Drug Information Journal. 34:115-116
Publikováno v:
The Hospice journal. 6(4)
The analgesic efficacy of oral controlled-release morphine (MS Contin Tablets; MSC) and its influence on quality of life, including parameters of nighttime sleep and daytime functioning, were evaluated in this open-label, sequential study in cancer p